AT Perspectives: Why Market Readiness Is the Bigger Commercialization Challenge for Startups

Q: In the path to successful commercialization, where do startups most often face challenges, product readiness or market readiness?

A: Commercialization succeeds at the intersection of product readiness and market readiness, but if forced to choose, market readiness is often the harder variable to master. A product can be scientifically sound, clinically validated, and operationally prepared, yet still struggle if the market isn’t ready to receive it.

Product readiness is largely within a company’s control. Development milestones, regulatory approvals, manufacturing plans. These follow defined pathways. While complex and resource-intensive, they benefit from clear frameworks and measurable progress.

Market readiness is less predictable. It requires a deep understanding of audience beliefs, unmet needs, competitive context, and behavioral barriers. It asks tougher questions: Does the market recognize the problem? Are stakeholders motivated to change? Is the value proposition clear and credible at the moment of decision?

In healthcare, market readiness is further complicated by multiple audiences, including patients, HCPs, and payers, each with different incentives and constraints. Aligning those perspectives takes more than awareness; it takes insight, education, and timing.

The most successful commercialization efforts don’t treat readiness as an either/or proposition. They evolve product and market in parallel, using early engagement to shape both. However, teams often overestimate how quickly markets move. Products can be ready long before mindsets are.

Ultimately, commercialization isn’t about launching; it’s about adoption. And adoption depends less on how ready the product is and more on how ready people are to believe, trust, and act. That’s the harder work, and the most important to get right.

AT Perspectives is a forum for AbelsonTaylor Group subject matter experts to weigh in on industry topics. Submit your questions to press@abelsontaylorgroup.com.